Action CHOSA CHOSA ONCOLOGY AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Chosa Oncology AB

Actions

CHOSA

SE0007784319

Cours en clôture NORDIC GROWTH MARKET
Autres places de cotation
 00:00:00 01/02/2024 		Varia. 5j. Varia. 1 janv.
0,53 SEK +51,43 % Graphique intraday de Chosa Oncology AB -.--% -6,03 %
30/04 Chosa Oncology AB annonce la démission de Lars Hedbys en tant que président CI
28/03 CHOSA Oncology nomme Claus Frisenberg Pedersen au poste de directeur commercial CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Chosa Oncology AB Announces Resignation of Lars Hedbys as Chairman
Chosa Oncology Names CFO, Chief Commercial Officer
CHOSA Oncology AB Announces Chief Financial Officer Changes
CHOSA Oncology Appoints Claus Frisenberg Pedersen as Chief Commercial Officer
Chosa Oncology AB Postpones Publication of Interim Report for the Second Quarter of 2023
CHOSA Oncology AB Publishes Results from Clinical Phase 2 Trial of Liposomal Formulation in Breast Cancer, Using Predictive Marker for Cisplatin
Chosa Oncology AB Announces Board Changes
CHOSA Oncology AB Presents Clinical Phase 2 Results of LiPlaCis and its Drug Response Predictor Test at ASCO 2023
CHOSA Oncology AB announces approved re-listing memorandum
CHOSA Oncology AB payback of convertible loan in process, update
CHOSA Oncology AB payback of convertible loan in process - update
CHOSA Oncology AB initiates payment of last portion of loan given to RhoVac AB
CHOSA Oncology AB initiates payment of last portion of loan given to RhoVac AB
RhoVac AB will Change its Name to CHOSA Oncology AB
RhoVac AB has Changed its Name to CHOSA Oncology AB
RhoVac AB (under name change to Chosa Oncology AB) has completed the acquisition of Chosa ApS and a new board and CEO have taken office
Rhovac AB Announces CEO Changes
RhoVac AB Announces Board Changes
Chosa ApS completed the acquisition of RhoVac AB from M2 Asset Management AB and others in a reverse merger transaction.
RhoVac's co-founder Anders Ljungqvist has passed away
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CHOSA
  4. Actualités Chosa Oncology AB
  5. Autres langues